DCB to support T1D1 – an app by the youngest participant of the Open Innovation Challenge
Berne and Washington D.C. – Today, DCB announced a collaboration with T1D1 (Type 1 From Day 1), an app by teenager Drew Mendelow. After his diagnosis with type 1 diabetes in 2020, the now 16-year old designed and built a mobile app to simplify diabetes management from day one of diagnosis. DCB is going to support the project with know-how and financial resources to develop the documentation needed to submit the T1D1 APP for approval with the FDA (US) as well as the European Union under the Medical Device Regulations (MDR).
The app currently has over 45,0000 downloads primarily in the US. The approval is necessary to continue usage and to be able to offer an adequate app solution for more people with diabetes in the future, both in Europe and in the US.
See also https://www.fox5dc.com/news/13-year-old-designs-app-to-help-children-battling-chronic-conditionand listen to the great story of Drew and his journey!
Drew Mendelow (Founder of T1D1) at the DCB Start-Up Night 2023
More recent news
DCB Newsletter #3/26: DID YOU KNOW… why type 1 diabetes is rising and what projections to 2050 tell us?
Dear Community, We are happy to provide you with a new episode of our “DID YOU KNOW…” series – this time with a focus...
DCB Newsletter #2/26: IT’S A WRAP! A Recap of The Insulin Insight Conference 2026
Dear Community, The Insulin Insight Conference 2026 recently took place at sitem-insel AG in Bern. It brought together...
DCB Newsletter #5/25: INSIDE DCB – Our Milestones in 2025
Dear DCB community, As we approach the end of this year, we want to take the opportunity to look back on our team’s...
DCB Research AG
Freiburgstrasse 3
3010 Bern
Schweiz